Jump to body content.
50th Ribbon 50th Ribbon

We are Kent logo

Orlando Bloom

Orlando Bloom


Orlando Bloom, a British actor, was born and raised in Canterbury and received an honorary degree from the University of Kent in July 2010.

After going to school in Canterbury, he became a member of the National Youth Theatre in London, earning a scholarship to train with the British American Drama Academy and going on to study at London's Guildhall School of Music and Drama.

Orlando Bloom first caught the attention of audiences and filmmakers as elf-prince Legolas in Peter Jackson's Academy Award-winning trilogy, The Lord of the Rings, going on to star as blacksmith Will Turner in the Pirates of the Caribbean - he will reprise this role in the fifth film of the series. In 2009, he was named a UNICEF Goodwill Ambassador and in 2014 he received a star of the Hollywood Walk of Fame.  (Read more...)

Tonbridge centre


For over 25 years, the University’s Tonbridge Centre has offered opportunities for both academic study and career progression, as well as bespoke training for local business and government communities.

Our facilities are situated in Tonbridge town centre, a few minutes' walk from the high street and Tonbridge railway station.

A vast array of engaging short courses and study days are available

at the Tonbridge Centre. They allow students who enrol on them to explore a subject purely for interest, among like-minded people, without formal assessment. Flexible study options are available each term across subjects such as: art history, creative writing, geology, history, literature, music, psychology, conservation, and politics.

The Centre is (Read more...)

Biopharmaceutical proteins

Biopharmaceutical proteins

School of Biosciences: Professor Robert Freedman, Professor Mick Tuite

The use of pharmaceutical drugs produced in living cells has been steadily rising, with many of the most common biopharmaceuticals being proteins. Research to improve the production and secretion of these protein drugs by cells has become a crucial part of drug discovery and development.

The patented technology developed

by Kent’s Robert Freedman and Mick Tuite in collaboration with the US pharmaceutical company Merck, can produce increases in the levels and authenticity of a range of high-value, secretory proteins. Several major pharmaceutical companies including Novozymes and Pfizer are using the technology to help develop and produce drugs for treating a wide range of human diseases, such as type 2 diabetes.

Development Office

Contact us: 50years@kent.ac.uk | T: +44 (0)1227 823729